A new treatment to protect chickens against infection has been developed in Australia with the aim of phasing out the use of antibiotics in the poultry industry.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


The system, developed by the country’s national science authority CSIRO, provides a way of delivering antibiotic alternatives – natural proteins called cytokines – into chickens, substances that are naturally produced by poultry.


CSIRO researcher Dr John Lowenthal said: “Cytokines improve the immune response during infection and help combat disease. As such, they are excellent naturally-occurring therapeutics.”


“When chickens were treated with cytokines their health improved and as a consequence they gained weight more quickly.”


The researchers administered cytokines into chickens using harmless vaccine strains of viruses called adenoviruses, similar to vaccine strains commonly used in the poultry industry.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The original genes expressing cytokines were obtained from a single, live chicken. The genes were then able to be copied indefinitely for use thereby avoiding the use of further chickens,” a researcher told just-food.com.

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact